ERBB2 and adenocarcinoma: The pathology showed an invasive poorly differentiated adenocarcinoma with signet ring features, microsatellite instability/mismatch repair (MMR) intact, human epidermal growth factor receptor 2 (HER2) negative, and programmed death‐ligand 1 (PD‐L1) 3%.